Unconscious classification of quantitative electroencephalogram features from propofol versus propofol combined with etomidate anesthesia using one-dimensional convolutional neural network

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Pan Zhou, Haixia Deng, Jie Zeng, Haosong Ran, Cong Yu
{"title":"Unconscious classification of quantitative electroencephalogram features from propofol versus propofol combined with etomidate anesthesia using one-dimensional convolutional neural network","authors":"Pan Zhou, Haixia Deng, Jie Zeng, Haosong Ran, Cong Yu","doi":"10.3389/fmed.2024.1447951","DOIUrl":null,"url":null,"abstract":"ObjectiveEstablishing a convolutional neural network model for the recognition of characteristic raw electroencephalogram (EEG) signals is crucial for monitoring consciousness levels and guiding anesthetic drug administration.MethodsThis trial was conducted from December 2023 to March 2024. A total of 40 surgery patients were randomly divided into either a propofol group (1% propofol injection, 10 mL: 100 mg) (P group) or a propofol-etomidate combination group (1% propofol injection, 10 mL: 100 mg, and 0.2% etomidate injection, 10 mL: 20 mg, mixed at a 2:1 volume ratio) (EP group). In the P group, target-controlled infusion (TCI) was employed for sedation induction, with an initial effect site concentration set at 5–6 μg/mL. The EP group received an intravenous push with a dosage of 0.2 mL/kg. Six consciousness-related EEG features were extracted from both groups and analyzed using four prediction models: support vector machine (SVM), Gaussian Naive Bayes (GNB), artificial neural network (ANN), and one-dimensional convolutional neural network (1D CNN). The performance of the models was evaluated based on accuracy, precision, recall, and F1-score.ResultsThe power spectral density (94%) and alpha/beta ratio (72%) demonstrated higher accuracy as indicators for assessing consciousness. The classification accuracy of the 1D CNN model for anesthesia-induced unconsciousness (97%) surpassed that of the SVM (83%), GNB (81%), and ANN (83%) models, with a significance level of <jats:italic>p</jats:italic> &amp;lt; 0.05. Furthermore, the mean and mean difference ± standard error of the primary power values for the EP and P groups during the induced period were as follows: delta (23.85 and 16.79, 7.055 ± 0.817, <jats:italic>p</jats:italic> &amp;lt; 0.001), theta (10.74 and 8.743, 1.995 ± 0.7045, <jats:italic>p</jats:italic> &amp;lt; 0.02), and total power (24.31 and 19.72, 4.588 ± 0.7107, <jats:italic>p</jats:italic> &amp;lt; 0.001).ConclusionLarge slow-wave oscillations, power spectral density, and the alpha/beta ratio are effective indicators of changes in consciousness during intravenous anesthesia with a propofol-etomidate combination. These indicators can aid anesthesiologists in evaluating the depth of anesthesia and adjusting dosages accordingly. The 1D CNN model, which incorporates consciousness-related EEG features, represents a promising tool for assessing the depth of anesthesia.Clinical Trial Registration<jats:ext-link>https://www.chictr.org.cn/index.html</jats:ext-link>.","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1447951","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

ObjectiveEstablishing a convolutional neural network model for the recognition of characteristic raw electroencephalogram (EEG) signals is crucial for monitoring consciousness levels and guiding anesthetic drug administration.MethodsThis trial was conducted from December 2023 to March 2024. A total of 40 surgery patients were randomly divided into either a propofol group (1% propofol injection, 10 mL: 100 mg) (P group) or a propofol-etomidate combination group (1% propofol injection, 10 mL: 100 mg, and 0.2% etomidate injection, 10 mL: 20 mg, mixed at a 2:1 volume ratio) (EP group). In the P group, target-controlled infusion (TCI) was employed for sedation induction, with an initial effect site concentration set at 5–6 μg/mL. The EP group received an intravenous push with a dosage of 0.2 mL/kg. Six consciousness-related EEG features were extracted from both groups and analyzed using four prediction models: support vector machine (SVM), Gaussian Naive Bayes (GNB), artificial neural network (ANN), and one-dimensional convolutional neural network (1D CNN). The performance of the models was evaluated based on accuracy, precision, recall, and F1-score.ResultsThe power spectral density (94%) and alpha/beta ratio (72%) demonstrated higher accuracy as indicators for assessing consciousness. The classification accuracy of the 1D CNN model for anesthesia-induced unconsciousness (97%) surpassed that of the SVM (83%), GNB (81%), and ANN (83%) models, with a significance level of p &lt; 0.05. Furthermore, the mean and mean difference ± standard error of the primary power values for the EP and P groups during the induced period were as follows: delta (23.85 and 16.79, 7.055 ± 0.817, p &lt; 0.001), theta (10.74 and 8.743, 1.995 ± 0.7045, p &lt; 0.02), and total power (24.31 and 19.72, 4.588 ± 0.7107, p &lt; 0.001).ConclusionLarge slow-wave oscillations, power spectral density, and the alpha/beta ratio are effective indicators of changes in consciousness during intravenous anesthesia with a propofol-etomidate combination. These indicators can aid anesthesiologists in evaluating the depth of anesthesia and adjusting dosages accordingly. The 1D CNN model, which incorporates consciousness-related EEG features, represents a promising tool for assessing the depth of anesthesia.Clinical Trial Registrationhttps://www.chictr.org.cn/index.html.
利用一维卷积神经网络对丙泊酚与丙泊酚联合依托咪酯麻醉的脑电图定量特征进行无意识分类
目的建立一个用于识别特征原始脑电图(EEG)信号的卷积神经网络模型对于监测意识水平和指导麻醉用药至关重要。共有 40 名手术患者被随机分为异丙酚组(1% 异丙酚注射液,10 mL: 100 mg)(P 组)或异丙酚-依托咪酯组合组(1% 异丙酚注射液,10 mL: 100 mg,和 0.2% 依托咪酯注射液,10 mL: 20 mg,以 2:1 的体积比混合)(EP 组)。P 组采用目标控制输注(TCI)进行镇静诱导,初始效应部位浓度设定为 5-6 μg/mL。EP 组接受静脉推注,剂量为 0.2 mL/kg。从两组中提取了六个与意识相关的脑电图特征,并使用四种预测模型进行分析:支持向量机(SVM)、高斯直觉贝叶斯(GNB)、人工神经网络(ANN)和一维卷积神经网络(1D CNN)。结果功率谱密度(94%)和阿尔法/贝塔比(72%)作为意识评估指标表现出较高的准确性。一维 CNN 模型对麻醉诱导昏迷的分类准确率(97%)超过了 SVM(83%)、GNB(81%)和 ANN(83%)模型,显著性水平为 p &p;lt;0.05。此外,EP 组和 P 组在诱导期的主要功率值的平均值和平均差±标准误差如下:delta(23.85 和 16.79,7.055 ± 0.817,p &;lt;0.001)、theta(10.74 和 8.743,1.995 ± 0.7045,p &;lt; 0.结论大慢波振荡、功率谱密度和阿尔法/贝塔比是丙泊酚-乙托咪酯联合静脉麻醉期间意识变化的有效指标。这些指标可帮助麻醉医师评估麻醉深度并相应调整剂量。一维CNN模型结合了与意识相关的脑电图特征,是评估麻醉深度的一种很有前途的工具。临床试验注册https://www.chictr.org.cn/index.html。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信